Therapeutic agents

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/47 (2006.01) A61K 31/55 (2006.01) A61K 31/675 (2006.01) A61K 38/05 (2006.01)

Patent

CA 2049980

Abstract Therapeutic Agents A method for the treatment of heart failure in a human in need of such treatment which comprises the administration to the human of a therapeutically effective amount of an angiotensin-converting enzyme (ACE) inhibitor and a therapeutically effective amount of a compound of formula I Image wherein n is 1 or 2. A preferred method of the invention comprises the treatment of chronic heart failure in a human by oral administration of a compound of formula I and an ACE inhibitor. The preferred compound of formula I is 7-fluoro-1-methyl-3-methyl- sulphinyl-4-quinolone. The compound of formula I and the ACE inhibitor may be administered concomitantly or concurrently and combined preparations for simultaneous, separate or sequential use are described. Concomitant administration may be by novel pharmaceutical compositions comprising a compound of formula I, an ACE inhibitor and a pharmaceutically acceptable carrier.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Therapeutic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic agents will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1823002

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.